Home › Funds › WORLDQUANT MILLENNIUM ADVISORS LLC › REGN
WORLDQUANT MILLENNIUM ADVISORS LLC position in REGN
REGENERON PHARMACEUTICALS · Health Care
WORLDQUANT MILLENNIUM ADVISORS LLC reported holding 353,970 shares of REGN (REGENERON PHARMACEUTICALS) in its Q2 2026 13F filing — a position valued at US$220.7M, representing 0.76% of its reported portfolio and ranking #19 among its reported holdings. WORLDQUANT MILLENNIUM ADVISORS LLC has disclosed REGN holdings in 10 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How WORLDQUANT MILLENNIUM ADVISORS LLC's REGN position evolved
WORLDQUANT MILLENNIUM ADVISORS LLC first disclosed a stake in REGN in Q3 2023 at 17,180 shares (US$14.1M). The position peaked in Q2 2026 at 353,970 shares, worth US$220.7M. Across 10 filings, WORLDQUANT MILLENNIUM ADVISORS LLC increased the stake 3 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 353,970 shares valued at US$220.7M — an increase of 253,301 shares quarter over quarter.. Notable position changes include a 91% trim in Q4 2023 (shares rose 10% over the following quarter), a 70% trim in Q1 2024 (shares rose 9% over the following quarter), a 252% increase in Q2 2026 (shares rose 22% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 17.18K | $14.14M | New |
| Q4 2023 | 1.50K | $1.32M | Reduce |
| Q1 2024 | 449 | $432.16K | Reduce |
| Q3 2024 | 121.28K | $127.49M | New |
| Q4 2024 | 105.31K | $75.01M | Reduce |
| Q1 2025 | 129.80K | $82.32M | Add |
| Q3 2025 | 67.38K | $37.89M | New |
| Q4 2025 | 59.35K | $45.81M | Reduce |
| Q1 2026 | 100.67K | $77.78M | Add |
| Q2 2026 | 353.97K | $220.71M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About REGN and 13F data
REGN (REGENERON PHARMACEUTICALS) is a Health Care company. 31 other funds we track also report a position in REGN — the largest reported positions include Dodge & Cox (US$3.04B), DODGE & COX (US$3.04B), LOOMIS SAYLES & CO L P (US$1.16B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding REGN
- Dodge & Cox 4.87M sh · $3.04B · Q2 2026
- DODGE & COX 4.87M sh · $3.04B · Q2 2026
- LOOMIS SAYLES & CO L P 1.86M sh · $1.16B · Q2 2026
More on WORLDQUANT MILLENNIUM ADVISORS LLC
FAQ
How long has WORLDQUANT MILLENNIUM ADVISORS LLC held REGN?
WORLDQUANT MILLENNIUM ADVISORS LLC has disclosed REGN holdings in 10 of the last 12 reported quarters, going back to Q3 2023.
What is WORLDQUANT MILLENNIUM ADVISORS LLC's current position in REGN?
As of Q2 2026, WORLDQUANT MILLENNIUM ADVISORS LLC holds 353.97K shares of REGN (REGENERON PHARMACEUTICALS), valued at $220.71M, representing 0.76% of its reported portfolio and ranking #19.
Has WORLDQUANT MILLENNIUM ADVISORS LLC been buying or selling REGN?
In the latest 13F filing (Q2 2026), WORLDQUANT MILLENNIUM ADVISORS LLC increased its position in REGN. The position peaked in Q2 2026 at 353.97K shares.
Which other funds hold REGN?
Other major institutional holders of REGN include Dodge & Cox, DODGE & COX, LOOMIS SAYLES & CO L P, among 31 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.